Pediatric palliative care programs in children's hospitals: a cross-sectional national survey

Chris Feudtner1, James Womer, Rachel Augustin

  • 1CHOP North, Room 1523, The Children's Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA 10194. feudtner@email.chop.edu.

Pediatrics
|November 6, 2013
PubMed

Insights

Pediatric palliative care (PPC) programs are increasingly common in children's hospitals. However, there is significant variation in staffing, funding, and services offered, highlighting a need for standardized guidelines.

Area of Science:

  • Healthcare Management
  • Pediatrics
  • Palliative Care

Background:

  • Pediatric palliative care (PPC) programs provide comprehensive care for seriously ill children.
  • The establishment of PPC programs in children's hospitals has grown, but data on their scope is limited.

Purpose of the Study:

  • To assess the current landscape of pediatric palliative care programs in US children's hospitals.
  • To understand the number, staffing, services, funding, and distribution of these programs.

Main Methods:

  • A survey was distributed in 2012 to 226 hospitals identified by the National Association of Children's Hospitals and Related Institutions.
  • Data collected included program existence, staffing, patient demographics, services, and financial support.

Main Results:

  • 69% of responding hospitals (162 total) reported having a PPC program.
  • Most programs offer inpatient services during weekdays and rely heavily on hospital funding.
  • Program consults varied, correlating with hospital size and staff numbers.

Conclusions:

  • PPC programs are prevalent but show considerable variability in staffing, funding, and consultation volume.
  • Development of guidelines for PPC team composition, funding, and consultation standards is recommended to ensure quality care.
Abstract

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K